Skip to main content

Advertisement

Table 1 The correlation of RAC3 expression levels and clinical-pathological features in CRC

From: RAC3 influences the chemoresistance of colon cancer cells through autophagy and apoptosis inhibition

Variable Number of patients RAC3 expression (qPCR) Fisher’s (P)
< 1 10–100 > 100
Normal tissue 3a 3 (100)    
 Gender 0.5055
  Male 5 2 (40.0) 2 (40.0) 1 (20.0)  
  Female 9 1 (11.0) 6 (66.7) 2 (22.2)  
 Differentiation 0.5941
  Well 1 0 (0) 1 (100) 0 (0)  
  Moderate 11 3 (27.3) 7 (63.6) 1 (9.1)  
  Poor 2 0 (0) 0 (0) 2 (100)  
 Tumor status 0.4660
  T1 2 1 (50.0) 1 (50.0) 0 (0)  
  T2 0 0 (0) 0 (0) 0 (0)  
  T3 10 2 (20.0) 6 (60.0) 2 (20.0)  
  T4 2 0 (0) 1 (50.0) 1 (50.0)  
 Nodal status 0.1280
  N0 9 3 (33.3) 4 (44.4) 2 (22.2)  
  N1–2 5 0 (0) 4 (80.0) 1 (20.0)  
 Metastasis status 1.000
  M0 12 3 (25.0) 6 (50.0) 3 (25.0)  
  M1 2 0 (0) 2 (100) 0 (0)  
 Clinical stage 0.1923
  I + II 7 3 (42.9) 4 (57.1) 0 (0)  
  III + IV 7 0 (0) 4 (57.1) 3 (42.9)  
  1. acorrespond to 3 female patients